Search hospitals > Colorado > Boulder
Boulder Community Hospital
Claim this profileBoulder, Colorado 80301
Global Leader in Breast Cancer
Global Leader in Skin Cancer
Conducts research for Thyroid Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
278 reported clinical trials
2 medical researchers
Summary
Boulder Community Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Breast Cancer, Skin Cancer, Thyroid Cancer, Lung Cancer, Lymphoma and other specialties. Boulder Community Hospital is involved with conducting 278 clinical trials across 386 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Keren Sturtz.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Skin Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Keren SturtzSCL Health Lutheran Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
14 drugs studied
Clinical Trials running at Boulder Community Hospital
Lung Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Multiple Myeloma
Squamous Cell Carcinoma
ALK Gene Rearrangement
Breast Cancer
Cutaneous Melanoma
Plasma Cell Neoplasm
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Boulder Community Hospital?
Boulder Community Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Breast Cancer, Skin Cancer, Thyroid Cancer, Lung Cancer, Lymphoma and other specialties. Boulder Community Hospital is involved with conducting 278 clinical trials across 386 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Keren Sturtz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.